DETERMINING TREATMENT PREFERENCE FOR TOLVAPTAN IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE- DEVEOPMENT OF A DISCRETE CHOICE EXPERIMENT FOR USE AS A CLINICAL STUDY ENDPOINT
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1006
https://www.valueinhealthjournal.com/article/S1098-3015(16)01074-3/fulltext
Title :
DETERMINING TREATMENT PREFERENCE FOR TOLVAPTAN IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE- DEVEOPMENT OF A DISCRETE CHOICE EXPERIMENT FOR USE AS A CLINICAL STUDY ENDPOINT
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01074-3&doi=10.1016/j.jval.2016.03.1006
First page :
A252
Section Title :
Systemic Disorders/Conditions - Patient-Reported Outcomes & Patient Preference Studies
Open access? :
No
Section Order :
941